Grifols | GRFS - Costo Del Venduto

Prezzo Delle Azioni
7.71
Cambio Giornaliero
0.13 1.72%
Mensile
-14.99%
Annuale
-0.52%
Q1 Previsione
7.36




Costo Del Venduto Cambiamento Data
Alaunos Therapeutics USD 0 18K 2024-09
aTyr Pharma USD 3.34M 18.79M 2025-12
Cara Therapeutics USD 0 0 2025-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.51B 184.45M 2025-12
Infinity Pharmaceuticals USD 352K 89K 2023-06
Minerva Neurosciences 386K 31K 2024-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
TherapeuticsMD USD -11.99M 12.34M 2022-12